LMNR Limoneira CO Insider Trading

Director Slater Scott S buys 5.0K shares at $12.85 as LMNR stock down -46.1% from 52-week high amid -16.6% annual revenue decline

Director Slater Scott S purchased 5,000 shares of Limoneira at $12.85 on 2026-01-08, increasing his holdings to 64.4K shares (+8.4% vs pre-transaction). The buy occurs amid significant headwinds: the company reported a negative net income of $-855.0K for the latest quarter and was unprofitable over its most recent full fiscal year, while annual revenue declined -16.6% year-over-year. The stock trades at $13.50 currently, down -46.1% from its 52-week high of $25.05 and down -8.1% over the past 30 days. This insider's cross-ticker track record shows only 1 prior buy with mixed results (avg 30d return +19.7%, avg 90d return -14.6%, 0% 90-day win rate), offering limited predictive value for this specific purchase at this ticker.

Director NOLAN PETER J buys 20,000 shares at $12.74 avg for $254.8K amid -16.6% revenue decline and unprofitability.

NOLAN PETER J, as Director, executed two separate purchases totaling 20,000 shares (1.8% increase in holdings) at an average price of $12.74, spending $254.8K. The timing of these open-market purchases follows a period of substantial stock price deterioration: the stock trades -49.5% below its 52-week high of $25.05 and has declined -9.6% over 30 days and -14.1% over 90 days. The company's fundamentals show material challenges: annual revenue declined -16.6% year-over-year to $47.5M quarterly revenue, and the company posted negative net income of $-855.0K most recently, with full-year profitability also negative. While NOLAN's cross-ticker track record shows 1 prior buy with a positive 90-day average return of +20.9% and a 100% win rate, this represents limited data and does not establish a predictive pattern for LMNR performance. The purchase occurs during a period of compressed valuation relative to the 52-week range, but against a backdrop of deteriorating operational performance and negative profitability.